RandallRStoltzMD

PubMed

• 10 citations
  Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK-906), a Novel Selective D 2 /D 3 Receptor Antagonist: A Phase 1 Randomized, Placebo-Controlled Singl...
  Roger Lewis Whiting, Borje Darpo, Chunlin Chen, Margaret S. Fletcher, Dan Combs, Hongqi Xue, Randall Stoltz> ;Clinical Pharmacology in Drug Development. 2021 Jan 18
• 48 citations
  CK-2127107 amplifies skeletal muscle response to nerve activation in humans.
  Jinsy A. Andrews, Timothy M. Miller, Vipin Vijayakumar, Randall Stoltz, Joyce K. James, Lisa Meng, Andrew A. Wolff, Fady I. Malik> ;Muscle & Nerve. 2018 May 1
• 8 citations
  The Absolute Bioavailability and Effect of Food on the Pharmacokinetics of Odanacatib: A Stable-Label i.v./Oral Study in Healthy Postmenopausal Women.
  Stefan Zajic, Stefaan Rossenu, David Hreniuk, Filippos Kesisoglou, Jacqueline B. McCrea, Fang Liu, Li Sun, Rose Witter, Don Gauthier, Roy Helmy, Darrick Joss, Tong Ni,...> ;Drug Metabolism and Disposition. 2016 Sep 1
• 27 citations
  Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm.
  Sonja Krösser, Peter Wolna, Tanya Fischer, Ursula Boschert, Randall Stoltz, Meijian Zhou, Borje Darpo> ;Journal of Clinical Pharmacology. 2015 Sep 1
• 27 citations
  Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 using Pupillometry as a Translational Biomarker in Rat and Human
  Linda M. Rorick-Kehn, Jennifer Witcher, Stephen L. Lowe, Celedon Gonzales, Mary Ann Weller, Robert Bell, John Hart, Anne B. Need, Jamie H. McKinzie, Michael A. Statnic...> ;The International Journal of Neuropsychopharmacology. 2015 Feb 1
• 63 citations
  Safety, tolerability, and pharmacokinetic evaluation of single‐ and multiple‐ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction...
  Stephen L. Lowe, Conrad J. Wong, Jennifer Witcher, Celedon Gonzales, Gemma L. Dickinson, Robert Bell, Linda M. Rorick-Kehn, MaryAnn Weller, Randall Stoltz, Jane Royalt...> ;Journal of Clinical Pharmacology. 2014 Sep 1
• 33 citations
  Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a r...
  Elizabeth K. Hussey, Robert L. Dobbins, Randall Stoltz, Nancy L. Stockman, Robin L. O'Connor-Semmes, Anita Kapur, Sharon C. Murray, Debbi Layko, Derek J. Nunez> ;Journal of Clinical Pharmacology. 2010 Jun 1
• 28 citations
  A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
  Daniel M. Bloomfield, Rajesh Krishna, David Hreniuk, Lisa Hickey, Kalyan Ghosh, Arthur J. Bergman, Jutta Miller, Maria Gutierrez, Randall Stoltz, Keith Gottesdiener, G...> ;Journal of Clinical Pharmacology. 2009 Aug 1
• 33 citations
  Metabolic Disposition of [14C]Bazedoxifene in Healthy Postmenopausal Women
  Appavu Chandrasekaran, William E. McKeand, Pamela Sullivan, William DeMaio, Randall Stoltz, JoAnn Scatina> ;Drug Metabolism and Disposition. 2009 Jun 1
• 7 citations
  Effect of casopitant, a novel NK-1 antagonist, on the pharmacokinetics of dolasetron and granisetron
  Brendan M. Johnson, Ke Zhang, Lin Yue, Lyndon C. Kirby, Peter F. Lebowitz, Randall Stoltz> ;Supportive Care in Cancer. 2009 Feb 10
• 65 citations
  Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Ralte...
  Matt S. Anderson, Thomas N. Kakuda, William D. Hanley, Jutta Miller, James Kost, Randall Stoltz, Larissa Wenning, Julie A. Stone, Richard M. W. Hoetelmans, John A. Wag...> ;Antimicrobial Agents and Chemotherapy. 2008 Dec 1
• 71 citations
  Effects of Age, Gender, and Race/Ethnicity on the Pharmacokinetics of Posaconazole in Healthy Volunteers
  Angela Sansone-Parsons, Gopal Krishna, Jason S. Simon, Peter Soni, Bhavna Kantesaria, Jerry Herron, Randall Stoltz> ;Antimicrobial Agents and Chemotherapy. 2007 Feb 1
• 28 citations
  Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers.
  Randall Stoltz, Simona Parisi, Ajit K. Shah, Alberto Macciocchi> ;Biopharmaceutics & Drug Disposition. 2004 Nov 1
• 16 citations
  Parecoxib sodium demonstrates gastrointestinal safety comparable to placebo in healthy subjects.
  Stuart I Harris, Randall R Stoltz, Dianne LeComte, Richard C. Hubbard> ;Journal of Clinical Gastroenterology. 2004 Aug 1
• 109 citations
  Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects.
  Randall Stoltz, Jong-Chol Cyong, Ajit K. Shah, Simona Parisi> ;Journal of Clinical Pharmacology. 2004 May 1
• Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
  Stoltz, R.R., Harris, S.I., Kuss, M.E., LeComte, D., Talwalker, S., Dhadda, S., Hubbard, R.C.> ;Am J Gastroenterol. 2002 Jan
• 28 citations
  Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia.
  Helene D. Sabia, Pratapa Prasad, Harold T. Smith, Randall Stoltz, Paul Rothenberg> ;Journal of Cardiovascular Pharmacology. 2001 May 1
• 28 citations
  Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers.
  Tacey X. Viegas, George A. Omura, Randall Stoltz, James Kisicki> ;Journal of Clinical Pharmacology. 2000 Apr 1
• 35 citations
  Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.
  Evan A. Stein, Jonathan L. Isaacsohn, Randall Stoltz, Arthur Mazzu, Ming-Chung Liu, Cindy Lane, Allen H. Heller> ;The American Journal of Cardiology. 1999 May 15
• 231 citations
  Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis
  Thomas B. Casale, I.L. Bernstein, William W. Busse, C. LaForce, David G. Tinkelman, R.R. Stoltz, Dockhorn Rj, James D. Reimann, Su Jq, Fick Rb, Daniel C. Adelman> ;The Journal of Allergy and Clinical Immunology. 1997 Jul 1
• 32 citations
  Gastric emptying, pulmonary function, gas exchange, and respiratory quotient after feeding a moderate versus high fat enteral formula meal in chronic obstructive pulmo...
  Salim S. Akrabawi, Sohrab Mobarhan, Randall R. Stoltz, Paul W. Ferguson> ;Nutrition. 1996 Apr 1
• Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study.
  Goldstein, D. J., Wang, O., Saper, J. R., Stoltz, R., Silberstein, S. D., Mathew, N. T.> ;Cephalalgia. 1997 Nov
• Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme ...
  Black, H. R., Graff, A., Shute, D., Stoltz, R., Ruff, D., Levine, J., Shi, Y., Mallows, S.> ;J Hum Hypertens. 1997 Aug
• Reduction of serum lactate by sodium dichloroacetate, and human pharmacokinetic-pharmacodynamic relationships.
  Fox, A. W., Sullivan, B. W., Buffini, J. D., Neichin, M. L., Nicora, R., Hoehler, F. K., O'Rourke, R., Stoltz, R. R.> ;J Pharmacol Exp Ther. 1996 Nov
• A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
  Musselman, D. M., Ford, A. P., Gennevois, D. J., Harbison, M. L., Laurent, A. L., Mokatrin, A. S., Stoltz, R. R., Blue, D. R.> ;BJU Int. 2004 Jan
• Join now to see all